COMPANIES COVERED
Smith & NephewDownload FREE Report Sample
Download Free sampleEpistaxis, also known as nosebleed, occurs due to rupturing of a small blood vessel in the lining of nose, as the interior of the nose is highly delicate and sensitive and could not tolerate certain factors that make them fragile and prone to burst resulting in bleeding. Nosebleeds are common mostly during winter, as more of the upper respiratory infections occur during this season.
Epistaxis Market contains market size and forecasts of Epistaxis in global, including the following market information:
Global Epistaxis Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Epistaxis Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Epistaxis companies in 2021 (%)
The global Epistaxis market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Vasoconstrictors Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Epistaxis include Smith & Nephew, Medline, Bristol-Myers Squibb Pharma Company, Ciron Drugs and King Pharmaceuticals, Inc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Epistaxis manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Epistaxis Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Epistaxis Market Segment Percentages, by Type, 2021 (%)
Vasoconstrictors
Anesthetics
Antibiotic Ointments
Cauterizing Agents
Global Epistaxis Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Epistaxis Market Segment Percentages, by Application, 2021 (%)
Pediatric
Adult
Global Epistaxis Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Epistaxis Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Epistaxis revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Epistaxis revenues share in global market, 2021 (%)
Key companies Epistaxis sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Epistaxis sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Smith & Nephew
Medline
Bristol-Myers Squibb Pharma Company
Ciron Drugs
King Pharmaceuticals, Inc
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy